Abstract LB389: Highly potent and selective RET inhibitor with robust anti-tumor activities against wild-type and acquired drug-resistant mutations
Authors: Li Xing, Wei Zhu, Jingbing Wang
Published: 2024-04-05
DOI:
10.1158/1538-7445.am2024-lb389
Source:
Full article
Abstract
Abstract